Cairo – Mubasher: Alexandria Pharmaceuticals and Chemical Industries reported net profit of EGP 110.9 million during fiscal year 2018/2019, down from EGP 118.2 million in the year-ago period.
Year-on-year, sales rose to EGP 829 million in FY18/19, compared to EGP 708.7 million, according to a statement to the Egyptian Exchange (EGX) on Sunday.
During the first eleven months of FY18/19, the company’s net profits dropped to EGP 147.59 million, compared to EGP 162.05 million in the corresponding period a year earlier.
